|Bid||24.00 x 100|
|Ask||37.50 x 200|
|Day's range||29.92 - 30.94|
|52-week range||11.49 - 32.94|
|PE ratio (TTM)||N/A|
|Earnings date||1 Nov 2017 - 6 Nov 2017|
|Forward dividend & yield||N/A (N/A)|
|1y target est||39.86|
Insmed Incorporated (INSM) needs investors to pay close attention to the stock based on moves in the options market lately.
On a per-share basis, the Bridgewater, New Jersey-based company said it had a loss of 69 cents. The results matched Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment ...
Insmed, maker of the new drug Alis, said it will use the proceeds of the stock offering to push the medication to market.